← Leaderboards
Craig Cohen
Social And Scientific Systems, Inc.
$5,227,042
Attributed
$5,227,042
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2015–19$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,227,042 · 1
By mechanism
N01$5,227,042 · 1
Top collaborators
No co-investigators on record.
Most similar at Social And Scientific Systems, Inc.
Same institution · by research overlap
- David Wagner$40,506,988
- Fred M Gordin$135,145,810
- Jeffrey Klausner$10,866,105
- Klausner Jeffrey$2,143,164
- Kerry James$3,054,178
Others in their field
Top investigators on “Vaginitis”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$119,511,781
- Wafaa M. El-Sadr · Columbia University Health Sciences$111,469,358
- Myron S Cohen · Family Health International$91,263,426
- Elaine D. Eaker · Eaker Epidemiology Enterprises, Llc$63,680,802
- Tracey Devoir · Booz Allen Hamilton, Inc.$49,200,509
- Ian Michael McGowan · University Of California Los Angeles$46,440,671
Research focus
VaginitisBiologicalClinical ResearchClinical Research SiteClinical TrialsClinical Trials Cooperative GroupSample CollectionSexually Transmitted DiseasesTherapeutic DevelopmentTrainingBacterial VaginosisLeadershipPreventProtocol DevelopmentRecurrenceHuman ResourcesLaboratoriesResearch InfrastructureInfrastructureLaboratory Personnel
Grant awards (4)
PHASE II-B CLINICAL TRIAL TO PREVENT THE RECURRENCE OF BACTERIAL VAGINOSIS$408,177
N01 · FY2019 · AI · contact PI
PHASE II-B CLINICAL TRIAL TO PREVENT THE RECURRENCE OF BACTERIAL VAGINOSIS$821,977
N01 · FY2018 · AI · contact PI
PHASE II-B CLINICAL TRIAL TO PREVENT THE RECURRENCE OF BACTERIAL VAGINOSIS$1,811,664
N01 · FY2017 · AI · contact PI
PHASE II-B CLINICAL TRIAL TO PREVENT THE RECURRENCE OF BACTERIAL VAGINOSIS$2,185,224
N01 · FY2015 · AI · contact PI